Cargando…
A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment
Dopamine replacement represents the standard therapy for Parkinson’s disease (PD), a common, chronic, and incurable neurological disorder; however, this approach only treats the symptoms of this devastating disease. In the search for novel disease-modifying therapies that target other relevant molec...
Autores principales: | Sanz, Francisco José, Solana-Manrique, Cristina, Torres, Josema, Masiá, Esther, Vicent, María J., Paricio, Nuria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804136/ https://www.ncbi.nlm.nih.gov/pubmed/34697772 http://dx.doi.org/10.1007/s13311-021-01134-2 |
Ejemplares similares
-
Disease-Modifying
Effects of Vincamine Supplementation
in Drosophila and Human Cell Models
of Parkinson’s Disease Based on DJ-1 Deficiency
por: Sanz, Francisco José, et al.
Publicado: (2023) -
Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency
por: Solana-Manrique, Cristina, et al.
Publicado: (2022) -
Differences in the renal antifibrotic signaling of serelaxin and zaprinast
por: Wetzl, Veronika, et al.
Publicado: (2015) -
Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases
por: Solana-Manrique, Cristina, et al.
Publicado: (2022) -
Infliximab reduces Zaprinast-induced retinal degeneration in cultures of porcine retina
por: Martínez-Fernández de la Cámara, Cristina, et al.
Publicado: (2014)